Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer
Open Access
- 1 March 2021
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 16 (9), 1427-1437
- https://doi.org/10.1002/cmdc.202000942
Abstract
The enzyme butyrylcholinesterase (BChE) represents a promising target for imaging probes to potentially enable early diagnosis of neurodegenerative diseases like Alzheimer's disease (AD) and to monitor disease progression in some forms of cancer. In this study, we present the design, facile synthesis, in vitro and preliminary ex vivo and in vivo evaluation of a morpholine‐based, selective inhibitor of human BChE as a positron emission tomography (PET) tracer with a pseudo‐irreversible binding mode. We demonstrate a novel protecting group strategy for 18F radiolabeling of carbamate precursors and show that the inhibitory potency as well as kinetic properties of our unlabeled reference compound were retained in comparison to the parent compound. In particular, the prolonged duration of enzyme inhibition of such a morpholinocarbamate motivated us to design a PET tracer, possibly enabling a precise mapping of BChE distribution.This publication has 74 references indexed in Scilit:
- Butyrylcholinesterase as a prognostic marker: a review of the literatureJournal of Cachexia, Sarcopenia and Muscle, 2012
- The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?ACS Medicinal Chemistry Letters, 2012
- Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in miceBehavioural Brain Research, 2011
- Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer diseaseAlzheimer's Research & Therapy, 2009
- The butyrylcholinesterase knockout mouse is obese on a high-fat dietChemico-Biological Interactions, 2008
- Inhibition of two different cholinesterases by tacrineChemico-Biological Interactions, 2006
- Cholinesterase activity of human lung tumours varies according to their histological classificationCarcinogenesis: Integrative Cancer Research, 2005
- Acetylcholinesterase Inhibitors: SAR and Kinetic Studies on ω-[N-Methyl-N-(3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyaryl DerivativesJournal of Medicinal Chemistry, 2001
- Prospective of human butyrylcholinesterase as a detoxifying antidote and potential regulator of controlled-release drugsDrug Development Research, 2000
- Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamidesJournal of Medicinal Chemistry, 1990